Загрузка...
Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer
PURPOSE: Synergy is observed with the combination of capecitabine and docetaxel due to docetaxel mediated up-regulation of thymidine phosphorylase. A phase II trial was performed with the combination for metastatic, castrate resistant prostate cancer. MATERIALS AND METHODS: Eligible patients had met...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3869185/ https://ncbi.nlm.nih.gov/pubmed/19447430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.02.105 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|